Bitwise Bitcoin ETF Common Shares of Beneficial Interest에 대한 매도 수량은 투자자에게 Bitwise Bitcoin ETF Common Shares of Beneficial Interest의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Bitwise Bitcoin ETF Common Shares of Beneficial Interest (ARCA:BITB), 공매도 수량 보고

In seeking to achieve its investment objective, the Trust will hold bitcoin and establish its net asset value (NAV) with reference to the CME CF Bitcoin Reference Rate - New York Variant (BRRNY)

Bitwise Bitcoin ETF

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ARKK

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

BITO

BITX

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

PLTR

TSLA

 아크 인베스트먼트 매니지먼트의 설립자 캐시 우드는 2024년 대선에서 도널드 트럼프가 카멀라 해리스를 물리치고 당선된 이후 인수합병(M&amp;A)이 급증할 것으로 예상했다.

캐시 우드의 예측: 트럼프 2기 M&amp;A 급증, &#34;금보다 더 희귀한 비트코인&#34; 지속 상승

BRRR

DEFI

유명한 암호화폐 분석가인 윌리 우(Willy Woo)는 비트코인 ETF의 도입이 비트코인(CRYPTO: BTC)의 가격을 금을 넘어서게 할 수도 있다고 예측했다.

비트코인 ETF로 킹 크립토의 시가총액이 금의 시가총액을 초월 가능: 분석가

Bitball Treasure

<p><strong>Vor Biopharma Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares are trading higher on Friday after the company announced it has entered into a securities <a href="https://www.benzinga.com//node/42701204">purchase agreement</a> for a private investment in public equity financing (PIPE).</p>
<p><strong>What To Know:</strong> The company expects to generate about $55.6 million in gross proceeds from the PIPE. Vor plans to utilize these proceeds in order to fund clinical and preclinical development of its pipeline candidates and for general corporate purposes.</p>
<p>As part of the PIPE, Vor will issue a total of 55,871,260 shares of common stock and accompanying warrants to purchase an additional 69,839,075 shares, priced at $0.99425 per share and warrants.</p>
<p>If exercised for cash, the warrants would result in additional gross proceeds to Vor of up to approximately $58.5 million.</p>
<p>The PIPE was led by <strong>Reid Hoffman</strong> who believes in the potential of Vor&#8217;s trem-cel therapy to treat acute myeloid leukemia. The therapy utilizes CRISPR/cas9 to modify the bone marrow of patients.</p>
<p>&#8220;Early data released by Vor suggest a potent effect, which now must be confirmed by future trials. I am delighted to support this company that uses a game-changing technology that will hopefully impact the lives of patients with this lethal cancer – but even more the trajectory of cancer therapy in general,&#8221; said Hoffman.</p>
<p><strong>Related Link: <a href="https://www.benzinga.com/insights/options/24/12/42705963/spotlight-on-solaredge-technologies-analyzing-the-surge-in-options-activity">Spotlight on SolarEdge Technologies: Analyzing the Surge in Options Activity</a></strong></p>
<p><strong>VOR Price Action:</strong> At the time of writing, Vor stock is trading 40.8% higher at $1.18, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><em>Image: Image: Emilian Danaila from Pixabay</em></p>


Movers

What's Going On With Vor Biopharma Shares Friday?

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>RH</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RH, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for RH.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 37% bullish and 37%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $167,309, and 4 are calls, for a total amount of $151,280.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $310.0 to $520.0 for RH over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for RH options trades today is 33.88 with a total volume of 208.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for RH's big money trades within a strike price range of $310.0 to $520.0 over the last 30 days.</p>
<h3>RH 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735325139_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$22.5</td>
<td>$20.3</td>
<td>$22.5</td>
<td>$520.00</td>
<td>$67.5K</td>
<td align="right">22</td>
<td align="right">0</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$43.7</td>
<td>$42.0</td>
<td>$42.0</td>
<td>$390.00</td>
<td>$63.0K</td>
<td align="right">21</td>
<td align="right">15</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.3</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$365.00</td>
<td>$53.7K</td>
<td align="right">1</td>
<td align="right">131</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$152.5</td>
<td>$145.1</td>
<td>$149.0</td>
<td>$360.00</td>
<td>$29.8K</td>
<td align="right">18</td>
<td align="right">2</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$141.3</td>
<td>$133.3</td>
<td>$137.3</td>
<td>$310.00</td>
<td>$27.4K</td>
<td align="right">74</td>
<td align="right">2</td>
</tr>
</tbody>
</table>
</p>
<h3>About RH</h3>
<p>RH is a luxury furniture and lifestyle retailer operating in the $134 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 19 restaurant locations. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in bespoke furniture, architecture, media, and more.</p>
<p>Following our analysis of the options activities associated with RH, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of RH</h3>
<ul>
<li>With a trading volume of 133,668, the price of RH is down by -0.3%, reaching $405.78.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for RH</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $438.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Loop Capital persists with their Hold rating on RH, maintaining a target price of $450.<br />
&#x2A; An analyst from Baird persists with their Neutral rating on RH, maintaining a target price of $400.<br />
&#x2A; An analyst from Telsey Advisory Group has decided to maintain their Market Perform rating on RH, which currently sits at a price target of $480.<br />
&#x2A; An analyst from Morgan Stanley persists with their Equal-Weight rating on RH, maintaining a target price of $435.<br />
&#x2A; An analyst from Guggenheim has revised its rating downward to Buy, adjusting the price target to $425. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest RH options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

This Is What Whales Are Betting On RH

<p>Deep-pocketed investors have adopted a bullish approach towards Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MO usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 19 extraordinary options activities for Altria Group. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 47% leaning bullish and 47% bearish. Among these notable options, 8 are puts, totaling $746,410, and 11 are calls, amounting to $1,187,025.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $37.5 to $55.0 for Altria Group over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Altria Group stands at 1434.1, with a total volume reaching 32,436.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Altria Group, situated within the strike price corridor from $37.5 to $55.0, throughout the last 30 days.</p>
<h3>Altria Group Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735325134_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$8.45</td>
<td>$8.35</td>
<td>$8.45</td>
<td>$45.00</td>
<td>$252.6K</td>
<td>528</td>
<td>300</td>
</tr>
<tr>
<td>MO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.8</td>
<td>$0.76</td>
<td>$0.8</td>
<td>$50.00</td>
<td>$232.4K</td>
<td>3.4K</td>
<td>9.0K</td>
</tr>
<tr>
<td>MO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$45.00</td>
<td>$223.8K</td>
<td>2.0K</td>
<td>274</td>
</tr>
<tr>
<td>MO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.1</td>
<td>$6.0</td>
<td>$6.1</td>
<td>$47.50</td>
<td>$181.7K</td>
<td>2.5K</td>
<td>300</td>
</tr>
<tr>
<td>MO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$12.8</td>
<td>$12.7</td>
<td>$12.77</td>
<td>$40.00</td>
<td>$109.8K</td>
<td>723</td>
<td>86</td>
</tr>
</tbody>
</table>
</p>
<h3>About Altria Group</h3>
<p>Altria comprises Philip Morris USA, us Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the us with 42% annual share in 2023. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev, a 42% stake in cannabis manufacturer Cronos, acquired Njoy Holdings in 2023, and operates a joint venture with Japan Tobacco in the heated tobacco category. It also recently disposed of its investment in Juul Labs.</p>
<p>Following our analysis of the options activities associated with Altria Group, we pivot to a closer look at the company's own performance.</p>
<h3>Altria Group's Current Market Status</h3>
<ul>
<li>With a volume of 2,514,562, the price of MO is down -0.46% at $52.36. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 34 days.</li>
</ul>
<h3>What Analysts Are Saying About Altria Group</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $65.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities upgraded its action to Buy with a price target of $65. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Altria Group with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Altria Group Options Trading: A Deep Dive into Market Sentiment

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>TeraWulf</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with WULF, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 9 options trades for <strong>TeraWulf</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 44% bullish and 55%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $200,000, and 8, calls, for a total amount of $342,400.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $2.0 to $12.0 for TeraWulf during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for TeraWulf's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of TeraWulf's whale activity within a strike price range from $2.0 to $12.0 in the last 30 days. </p>
<h3>TeraWulf Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735325129_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WULF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$0.5</td>
<td>$0.4</td>
<td>$0.5</td>
<td>$2.50</td>
<td>$200.0K</td>
<td>779</td>
<td>4.0K</td>
</tr>
<tr>
<td>WULF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.15</td>
<td>$1.0</td>
<td>$1.0</td>
<td>$12.00</td>
<td>$95.1K</td>
<td>3.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>WULF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.5</td>
<td>$2.45</td>
<td>$2.54</td>
<td>$7.00</td>
<td>$50.9K</td>
<td>724</td>
<td>604</td>
</tr>
<tr>
<td>WULF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.5</td>
<td>$2.45</td>
<td>$2.5</td>
<td>$7.00</td>
<td>$50.0K</td>
<td>724</td>
<td>804</td>
</tr>
<tr>
<td>WULF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.8</td>
<td>$1.7</td>
<td>$1.72</td>
<td>$4.00</td>
<td>$34.4K</td>
<td>14.8K</td>
<td>315</td>
</tr>
</tbody>
</table>
</p>
<h3>About TeraWulf</h3>
<p>TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.</p>
<h3>Present Market Standing of TeraWulf</h3>
<ul>
<li>Trading volume stands at 15,340,008, with WULF's price down by -8.06%, positioned at $5.59.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 81 days.</li>
</ul>
<h3>Expert Opinions on TeraWulf</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $10.25.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from B. Riley Securities keeps a Buy rating on TeraWulf with a target price of $10.<br />
&#x2A; Maintaining their stance, an analyst from Northland Capital Markets continues to hold a Outperform rating for TeraWulf, targeting a price of $10.<br />
&#x2A; Maintaining their stance, an analyst from Rosenblatt continues to hold a Buy rating for TeraWulf, targeting a price of $10.<br />
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $11.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for TeraWulf, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


WULF

TeraWulf Unusual Options Activity

<p><strong>Goldman Sachs</strong> analyst Jordan Alliger reiterated the Buy rating on <strong>J.B. Hunt Transport Services, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>).</p>
<p>The analyst&#8217;s take on <strong>J.B. Hunt</strong> suggests a positive outlook. The company showed a 5% growth in intermodal in the third quarter of 2024, driven by a 7% increase in transcontinental and <a target="_blank" href="https://www.benzinga.com/quote/jbht/analyst-ratings" rel="noreferrer noopener">double-digit growth in Southern California.</a></p>
<p>However, according to Alliger, the company&#8217;s intermodal growth lags behind the &#8220;Big Three&#8221; ports, which saw an average increase of 27.5%.</p>
<p>The Big Three West Coast Ports, represented by L.A., Long Beach, and Oakland, reported a 20% year-over-year increase in November 2024 traffic, surpassing the pre-pandemic five-year average of 2%.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701686/bitcoin-could-slide-to-60000-technical-analyst-warns" rel="noreferrer noopener">Bitcoin Could Slide To $60,000, Technical Analyst Warns</a></strong></p>
<p>However, sequentially, the combined data showed a 6% month-over-month decline, which is below the five-year average.</p>
<p>Despite this, the analyst predicts that the pace of growth could pick up again for J.B. Hunt<strong> </strong>toward the end of 2024 and into 2025, ahead of any potential tariffs.</p>
<p>The shift towards domestic intermodal is showing positive signs, and there is potential for more imports to move out of West Coast warehouses.</p>
<p>The West Coast ports, regaining share in 2023 and 2024, may further boost J.B. Hunt&#8217;s performance if more ocean freight is diverted to the West Coast amid ongoing contract uncertainties on the East Coast. Despite this, the company&#8217;s growth is still behind the broader industry&#8217;s pace, but the outlook remains favorable with potential upside, Alliger adds.</p>
<p><strong>Price Action: </strong>JBHT shares are trading lower by 0.76% to $170.70&nbsp;at the last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42699697/bitcoin-ethereum-etfs-break-4-day-outflow-streak-net-592-inflows-on-thursday" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum ETFs Break 4-Day Outflow Streak, Net $592 Inflows On Thursday</a></strong></li>
</ul>
<p><em>Photo via Wikimedia Commons</em></p>


Analyst Color

Equities

Analyst Ratings

Trading Ideas

General

JBHT

J.B. Hunt's Intermodal Growth Shows Promise Despite Lagging 'Big Three' Ports: Analyst

<p><strong>Johnson &amp; Johnson</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), the iconic healthcare giant known for its stable dividends and defensive appeal, has entered a bearish technical pattern: <a href="https://www.benzinga.com/topic/death-cross">the <strong>Death Cross</strong></a>. </p>
<p>This occurs when the stock's 50-day moving average falls below its 200-day moving average, signaling potential downside.</p>
<p><figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="810" height="546" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross.jpg" alt="" class="wp-image-709568" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross.jpg 810w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross-300x202.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27121413/JNJ-Death-Cross-768x518.jpg 768w" sizes="(max-width: 810px) 100vw, 810px" /></a></figure></p>
<p><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><em>Chart created using Benzinga Pro</em></a></p>
<h2 class="wp-block-heading">JNJ Stock Chart: Bearish Signals Abound</h2>
<p>JNJ stock, at $145.58, is below critical moving averages across the board. Its 20-day ($144.97), 50-day ($154.24) and 200-day ($154.66) moving averages suggest the trend is firmly bearish. With a MACD of a negative 2.72 and a Relative Strength Index of 36.84, the technical setup doesn't inspire confidence.</p>
<p>The one silver lining? JNJ stock's eight-day simple moving average of $144.97 is slightly below its current price, flashing a rare bullish signal amid the gloom.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/general/biotech/24/12/42535810/fda-rejects-johnson-johnsons-injectable-version-of-approved-drug-for-lung-cancer">FDA Rejects Johnson &amp; Johnson&#8217;s Injectable Version Of Approved Drug For Lung Cancer</a></strong></p>
<h2 class="wp-block-heading">Johnson &amp; Johnson&#8217;s Strategic Moves In Dermatology</h2>
<p>While the charts tell one story, Johnson &amp; Johnson's business narrative points to another. The company recently inked a licensing deal with Kaken Pharmaceutical for KP-723, a promising candidate targeting atopic dermatitis (AD), also known as eczema. With plans to launch a phase I study in 2025, Johnson &amp; Johnson is positioning itself to address significant unmet needs in autoimmune and allergic diseases.</p>
<p>This move aligns with the company's strategic focus on differentiated mechanisms of action in dermatology. Johnson &amp; Johnson's acquisitions in 2024 also bolstered its dermatology pipeline, emphasizing innovative treatments for AD and other immune-mediated conditions.</p>
<h2 class="wp-block-heading">Dividend Reliability Meets Bearish Momentum</h2>
<p>Johnson &amp; Johnson's long-standing reputation as a dividend aristocrat—boasting 60+ years of consistent payouts—continues to provide a safety net for investors. </p>
<p>With ample liquidity, low leverage, and robust free cash flow, the company's dividend sustainability remains solid even in the face of technical bearishness.</p>
<h2 class="wp-block-heading">The Verdict</h2>
<p>The Death Cross may cast a shadow over Johnson &amp; Johnson stock's short-term outlook, but its commitment to growth, innovation, and reliable dividends underscores its long-term appeal. </p>
<p>Investors should weigh JNJ stock&#8217;s bearish technical indicators against the company's strategic moves in dermatology and its history of weathering market storms.</p>
<p>As Johnson &amp; Johnson looks to tackle eczema and diversify its portfolio, the stock may be down but far from out. For now, the Death Cross is a storm cloud on the horizon—but every storm eventually passes.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://benzinga.com/analyst-ratings/analyst-color/24/12/42678014/top-7-blue-chip-stocks-with-the-best-return-potential-going-into-2025">Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025</a></strong></li>
</ul>
<p><em>Photo by Tada Images via Shutterstock</em>.</p>


Biotech

Health Care

Technicals

Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise

WIIM

Rumble shares are trading lower, possibly pulling back after the stock's recent surge.

<p>Looking into the current session, <strong>Bank of New York Mellon Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>)</strong> shares are trading at $77.72, after a <strong>0.80%</strong> decrease. Over the past month, the stock decreased by <strong>5.62%</strong>, but over the past year, it actually spiked by <strong>47.51%</strong>. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735324215_0.png" alt="Past Year Chart" /></p>

<h3>A Look at Bank of New York Mellon P/E Relative to Its Competitors</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Bank of New York Mellon has a lower P/E than the aggregate P/E of <strong>43.67</strong> of the Capital Markets industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735324215_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

Price Over Earnings Overview: Bank of New York Mellon

<p>Jensen Huang, the CEO and cofounder of Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), is making headlines for more than just his company's dominance in AI chips. Huang is allegedly leveraging <a href="https://www.benzinga.com/money/how-to-reduce-taxable-income-for-high-earners">legal tax strategies</a> to protect an estimated $8 billion from federal estate and gift taxes, according to a recent investigation by The New York Times. This staggering number has spurred a wider discussion about how the ultrawealthy use legal loopholes to safeguard their money.</p>
<h2 class="wp-block-heading">The NYT's Findings on Huang's Wealth Strategies</h2>
<p>Huang&#8217;s net worth was $127 billion when the report was released in early December. According to the NYT, he has used a number of financial strategies to <a href="https://www.benzinga.com/money/ownwell">reduce estate taxes</a>. These include instruments such as donor-advised funds (DAFs), grantor-retained annuity trusts (GRATs) and irrevocable trusts. By doing so, Huang could pass on much of his fortune to his descendants with minimal tax liability.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</strong></a></strong></li>
<li><strong>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"><strong> </strong><strong>for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</strong></a></strong></li>
</ul>
<p>One of the most notable examples cited by the NYT involves an irrevocable trust Huang and his wife set up in 2012. They transferred Nvidia shares worth $7 million into the trust, which has since grown in value to over $3 billion. Normally, the tax on that kind of wealth would be about 40%, but the trust helps them pay much less – perhaps just a few hundred thousand dollars.</p>
<p>As Lewis &amp; Clark Law School professor Jack Bogdanski told the NYT, "You have an army of well-trained, brilliant people who sit there all day long, charging $1,000 an hour, thinking up ways to beat this tax. Don't expect anyone in Congress to stop this."</p>
<p><strong>See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks"><strong>this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</strong></a></strong></p>
<h2 class="wp-block-heading">What's the Bigger Picture?</h2>
<p>The NYT&#8217;s investigation provides a broader view of the continuous erosion of estate taxes over time. Huang&#8217;s tactics are becoming increasingly popular, even though these taxes are meant to impact only the wealthiest Americans. Thanks to these methods, experts estimate that about $200 billion gets passed down each year without being taxed.</p>
<p>To make matters worse, funding constraints have reduced the Internal Revenue Service&#8217;s (IRS) ability to enforce the law. During the early 1990s, audits of more than 20% of estate tax returns were conducted. The NYT reports that number has now fallen to roughly 3%.</p>
<p><strong>Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"><strong> </strong><strong>you can become an investor for $0.80 per share today.</strong></a></strong></p>
<h2 class="wp-block-heading">Charitable Contributions and Scrutiny</h2>
<p>While Huang's philanthropy is well-documented, critics also scrutinized his use of DAFs, which lack transparency and accountability. Through the Jen Hsun &amp; Lori Huang Foundation, the couple has <a href="https://www.benzinga.com/startups/24/10/41124309/nvidias-jensen-huangs-wealth-exploded-in-five-years-to-108-billion-heres-why-his-philanthropy-is-bei">donated Nvidia shares</a> worth hundreds of millions of dollars to these funds. Although these contributions reduce Huang's taxable estate, the funds are not required to distribute money to charities immediately, leaving room for criticism about their actual societal impact.</p>
<h2 class="wp-block-heading">The Debate Continues</h2>
<p>Huang's financial strategies highlight the growing divide between the ultrawealthy and the <a href="https://www.benzinga.com/general/24/04/38295912/biden-promised-irs-funding-wouldnt-increase-audits-for-regular-americans-as-irs-audits-poorest-ameri">broader taxpaying public</a>. While these tactics are legal, they underscore how accessible loopholes can result in massive tax savings for billionaires. As the debate over wealth inequality and tax fairness continues, Huang's story may become a case study in how the richest Americans protect their fortunes.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>with $1,000 you can invest at just $0.26/share!</strong></a></strong></li>
<li><strong>If there was a new fund backed by Jeff Bezos offering a</strong><strong> <a href="https://www.benzinga.com/money/arrived-private-credit-fund"><strong>7-9% target yield with monthly dividends would you invest in it</strong></a>?</strong></li>
</ul>


NVDA

NYT Report Says Jensen Huang, The CEO Of Nvidia And The 10th-Richest Person In The U.S., Trying To Allegedly Avoid $8 Billion In Taxes

GDS shares are trading higher on continued strength following a Tuesday report suggesting the company is considering an IPO of its data center assets in China.

<p>Wall Street turned volatile Friday as four days of gains give way to fresh selling pressure driven by investor uncertainty over the incoming Trump administration&#8217;s economic policies and the <a href="https://www.benzinga.com/topic/federal-reserve">Federal Reserve&#8217;s path forward.</a></p>
<p>Major indices experienced wide losses by midday trading in New York, nearly erasing prior gains seen earlier this week, clouding the outlook for a Santa Rally.</p>
<p>The tech-heavy Nasdaq 100 tumbled 2%, on track for its second-worst session this month. Both the S&amp;P 500 and the Dow saw notable losses, while small caps underperformed large-cap counterparts.</p>
<p>On the data front, the U.S. goods trade deficit widened to $102.86 billion in November 2024, surpassing expectations of $100.7 billion, as imports jumped 4.5%, according to an advance official estimate.</p>
<p>Treasury yields were little moved but remained elevated, with the long-dated 30-year yield hovering at the highest levels since May. </p>
<p>In commodities markets, oil emerged by rising 1%, with West Texas Intermediate light crude topping $70 per barrel amid recent declines in in commercial crude inventories.</p>
<p>In cryptocurrency markets <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dropped 1.7% to $94,000, heading for its second consecutive weekly loss— the first since September.</p>
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<tbody>
<tr>
<td><strong>Major Indices</strong></td>
<td><strong>Price</strong></td>
<td><strong>Chg</strong></td>
<td><strong>1-day %</strong></td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,739.03</td>
<td>-586.77</td>
<td>-1.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,934.68</td>
<td>-102.91</td>
<td>-1.7%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,326.63</td>
<td>-441.68</td>
<td>-2.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,226.71</td>
<td>-53.48</td>
<td>-2.3%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption"><em>Updated at 12:15 p.m. ET</em></figcaption></p></figure></p>
<p><strong>According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:</strong></p>
<ul>
<li>The&nbsp;<strong>SPDR S&amp;P 500 ETF Trust</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 1.6% to $591.61.</li>
<li>The&nbsp;<strong>SPDR Dow Jones Industrial Average&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 1.2% to $427.96.</li>
<li>The tech-heavy&nbsp;<strong>Invesco QQQ Trust Series</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) tumbled 2.1% to $518.58.</li>
<li>The&nbsp;<strong>iShares Russell 2000 ETF</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 2.3% to $220.55.</li>
<li>The&nbsp;<strong>Energy Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, flat for the day; the&nbsp;<strong>Technology Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 2.4%.</li>
</ul>
<h3 class="wp-block-heading">Friday Stock Movers</h3>
<ul>
<li><strong>Tesla Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) sank 4.8% as investors reassessed its valuation after a 73% year-to-date surge.</li>
<li>Crypto-related stocks pulled back strongly: <strong>KULR Technology Group Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) tumbled 7.4%, <strong>MicroStrategy Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) slipped 3.6% and <strong>Coinbase Global Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) fell 3.5%. </li>
<li><strong>Lamb Weston Holdings Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) gained 3.6% after shareholder <strong>Jana Partners</strong> added<strong> Jeff Delapp</strong> to its board nominee slate, signaling a potential board overhaul, according to a Friday regulatory filing.</li>
</ul>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/travel/24/12/42705878/airline-stocks-outperform-tech-in-2024-holiday-travel-expected-to-see-records-this-year">Airline Stocks Outperform Tech In 2024: Holiday Travel &#8216;Expected To See Records This Year&#8217;</a></strong></li>
</ul>
<p><em>Photo via Shutterstock. </em></p>


Large Cap

Bonds

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

COIN

SPDR Dow Jones Industrial Average ETF Trust

KULR

MSTR

Stocks Tumble As Traders Rethink Santa Rally, Crude Tops $70, Bitcoin Slips To $94,000: What's Driving Markets Friday?

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Qualcomm</strong>.</p>
<p>Looking at options history for Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $103,238 and 7, calls, for a total amount of $449,504.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $200.0 for Qualcomm over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Qualcomm options trades today is 1371.1 with a total volume of 892.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Qualcomm's big money trades within a strike price range of $105.0 to $200.0 over the last 30 days.</p>
<h3>Qualcomm Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735323340_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.0</td>
<td>$5.5</td>
<td>$5.5</td>
<td>$155.00</td>
<td>$194.1K</td>
<td>5.5K</td>
<td align="right">371</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$55.0</td>
<td>$49.95</td>
<td>$52.79</td>
<td>$125.00</td>
<td>$52.7K</td>
<td>49</td>
<td align="right">10</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$13.35</td>
<td>$13.3</td>
<td>$13.35</td>
<td>$165.00</td>
<td>$52.0K</td>
<td>2.5K</td>
<td align="right">52</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$52.55</td>
<td>$51.5</td>
<td>$51.5</td>
<td>$105.00</td>
<td>$51.5K</td>
<td>1.2K</td>
<td align="right">10</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$1.18</td>
<td>$1.1</td>
<td>$1.1</td>
<td>$175.00</td>
<td>$44.0K</td>
<td>76</td>
<td align="right">402</td>
</tr>
</tbody>
</table>
</p>
<h3>About Qualcomm</h3>
<p>Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.</p>
<p>Following our analysis of the options activities associated with Qualcomm, we pivot to a closer look at the company's own performance.</p>
<h3>Qualcomm's Current Market Status</h3>
<ul>
<li>With a volume of 1,611,809, the price of QCOM is down -1.23% at $156.58. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 33 days.</li>
</ul>
<h3>Professional Analyst Ratings for Qualcomm</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $180.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Melius Research lowers its rating to Hold with a new price target of $180.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Qualcomm with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


QCOM

Behind the Scenes of Qualcomm's Latest Options Trends

<p>Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for Amgen. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 42% bearish. Among these notable options, 9 are puts, totaling $525,048, and 5 are calls, amounting to $288,709.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $245.0 and $320.0 for Amgen, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Amgen options trades today is 139.83 with a total volume of 1,014.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Amgen's big money trades within a strike price range of $245.0 to $320.0 over the last 30 days.</p>
<h3>Amgen Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735323335_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$34.8</td>
<td>$34.25</td>
<td>$34.8</td>
<td>$280.00</td>
<td>$191.3K</td>
<td align="right">110</td>
<td align="right">55</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$17.35</td>
<td>$17.3</td>
<td>$17.35</td>
<td>$270.00</td>
<td>$104.0K</td>
<td align="right">18</td>
<td align="right">64</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$24.7</td>
<td>$22.3</td>
<td>$22.8</td>
<td>$310.00</td>
<td>$57.0K</td>
<td align="right">33</td>
<td align="right">28</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$30.85</td>
<td>$30.65</td>
<td>$30.85</td>
<td>$270.00</td>
<td>$52.4K</td>
<td align="right">289</td>
<td align="right">18</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$35.1</td>
<td>$34.5</td>
<td>$34.67</td>
<td>$295.00</td>
<td>$52.0K</td>
<td align="right">97</td>
<td align="right">24</td>
</tr>
</tbody>
</table>
</p>
<h3>About Amgen</h3>
<p>Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.</p>
<h3>Amgen's Current Market Status</h3>
<ul>
<li>Trading volume stands at 582,871, with AMGN's price down by -0.55%, positioned at $261.73.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 39 days.</li>
</ul>
<h3>What The Experts Say On Amgen</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $256.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities downgraded its action to Underperform with a price target of $256. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


AMGN

Looking At Amgen's Recent Unusual Options Activity

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Verizon Communications</strong>.</p>
<p>Looking at options history for Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) we detected 9 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 33% with bearish.</p>
<p>From the overall spotted trades, 6 are puts, for a total amount of $327,928 and 3, calls, for a total amount of $247,780.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $34.0 to $47.0 for Verizon Communications over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Verizon Communications's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Verizon Communications's whale activity within a strike price range from $34.0 to $47.0 in the last 30 days. </p>
<h3>Verizon Communications Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735323330_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>VZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$6.35</td>
<td>$6.3</td>
<td>$6.35</td>
<td>$34.00</td>
<td>$156.8K</td>
<td>467</td>
<td align="right">248</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$8.3</td>
<td>$8.2</td>
<td>$8.3</td>
<td>$47.00</td>
<td>$100.4K</td>
<td>1.1K</td>
<td align="right">122</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.15</td>
<td>$3.1</td>
<td>$3.15</td>
<td>$42.00</td>
<td>$81.2K</td>
<td>7.5K</td>
<td align="right">258</td>
</tr>
<tr>
<td>VZ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.75</td>
<td>$6.35</td>
<td>$6.4</td>
<td>$45.00</td>
<td>$64.0K</td>
<td>1.9K</td>
<td align="right">100</td>
</tr>
<tr>
<td>VZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.55</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$38.00</td>
<td>$52.5K</td>
<td>782</td>
<td align="right">158</td>
</tr>
</tbody>
</table>
</p>
<h3>About Verizon Communications</h3>
<p>Wireless services account for about 70% of Verizon Communications' total service revenue and nearly all of its operating income. The firm serves about 93 million postpaid and 20 million prepaid phone customers via its nationwide network, making it the largest US wireless carrier. Fixed-line telecom operations include local networks in the Northeast, which reach about 30 million homes and businesses and serve about 8 million broadband customers. Verizon also provides telecom services nationwide to enterprise customers, often using a mixture of its own and other carriers' networks. Verizon agreed to acquire Frontier Communications in September 2024.</p>
<h3>Where Is Verizon Communications Standing Right Now?</h3>
<ul>
<li>With a volume of 6,649,497, the price of VZ is down -0.25% at $39.86. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 28 days.</li>
</ul>
<h3>What Analysts Are Saying About Verizon Communications</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $45.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS persists with their Neutral rating on Verizon Communications, maintaining a target price of $45. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Verizon Communications options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Verizon Communications Unusual Options Activity

Macro Economic Events

Oil is trading higher. Chinese stimulus hopes may be lifting demand outlook. Additionally, EIA reported a larger-than-expected draw in US crude inventories.

Commodities

U.S. Baker Hughes Oil Rig Count Unchanged At 483

ATNF

180 Life Sciences Corp. shares are trading lower after the company announced the pricing of a $2.9 million registered direct offering.

USA Gasoline Inventories 1.630M Vs -1.000M Est.; 2.348M Prior

USA EIA Weekly Distillates Stocks -1.694M Vs -0.700M Est.; -3.180M Prior

USA Crude Oil Inventories -4.237M Vs -0.700M Est.; -0.934M Prior

Bitcoin soars past $100K and these 20 companies hold the most amount of the cryptocurrency

Cryptocurrencies: Bitcoin Skyrockets Toward $100K

Did We Learn Anything From The Sock Puppet In 2000?

3 Things I Think I Think - Strategic Reserves And Stuff

An Asset Allocation For 2025 And Beyond

Bitcoin New Bull Breakout Starts Soon

Bitcoin's 2025 Potential - What It Means For BITO Investors

George Selgin On Strategic Bitcoin Reserves, Debanking, And The Fed's Framework Review

Bitcoin exchange-traded funds (ETFs) in the U.S. experienced their largest-ever single-day outflow on Christmas Eve, with BlackRock's iShares Bitco...

Comments

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

매도 수량

Bitwise Bitcoin ETF Common Shares of Beneficial Interest (ARCA:BITB), 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌